Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001Transplantation

The Use of the Endothelin Receptor Antagonist, Tezosentan, Before or After Renal Ischemia Protects Renal Function1

View Full Paper
Ask AI
Bookmark
Share

Authors

SWS M WilhelmEli Lilly (Germany)NSNicholas T. StoweCleveland ClinicARAnn RobinsonAlameda Health System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wilhelm et al. (2001) studied this question.

synapsesocial.com/papers/6a9143d735eca4d44dab4e0ahttps://doi.org/10.1097/00007890-200101270-00007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of an endothelin-receptor antagonist on ischemic acute renal failure1994 · 86 citations
  2. 2Determination of Portal Insulin Absorption From Peritoneum via Novel Nonisotopic Method1990 · 54 citations
  3. 3THE ASYSTOLIC, OR NON-HEARTBEATING, DONOR1997 · 161 citations
  4. 4One Month of Sustained Release of Insulin from a Polymer Implant1980 · 105 citations